FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Lou Gehrigs Disease

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI. Investigator Erik R.

Power3 Medical Products, Inc. (PWRM.OB) plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.

Proper Power and Energy, Inc. (PPWE.OB) is an independent exploration and production company. The Company's operations are in Kentucky, which provides for low risk developmental drilling and production, and Utah, which the Company controls over 11,000 acres for its exploratory prospect.

Orofino Gold Corp. (ORFG.PK) acquired a 55% interest in the Mina Azul/La Estrella property with the rights to acquire up to 80%. By acquiring its interest in an established operating mine, Orofino has established itself as a serious participant in the effort to revitalize the Senderos de Oro mining scene.

Pages

ADVERTISE WITH US